Trial
NCT04379492
A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
—
Condition
COVID-19
Intervention
Hydroxychloroquine
Why stopped
Emerging evidence does not support the use of HCQ for treatment or prevention of SARS -CoV2 infection. No pts have been enrolled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-16